These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6850093)

  • 1. [Complement consumption as criterion of the tolerogenicity of a globulin preparation].
    Shemerovskaia TG; Sofronov BN
    Biull Eksp Biol Med; 1983 May; 95(5):71-3. PubMed ID: 6850093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lowering the complement-fixing capacity and induction of tolerogenic properties in human globulins by urea treatment].
    Shemerovskaia TG; Sofronov BN
    Biull Eksp Biol Med; 1986 Nov; 102(11):625-7. PubMed ID: 3779097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of MLV vector particles from human complement.
    Breun S; Salmons B; Günzburg WH; Baumann JG
    Biochem Biophys Res Commun; 1999 Oct; 264(1):1-5. PubMed ID: 10527830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of anticomplementary activity in therapeutic intravenous immunoglobulin preparations.
    Ramasamy I; Tran E; Farrugia A
    Biologicals; 1997 Mar; 25(1):87-92. PubMed ID: 9167012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Complement in organ xenotransplantation].
    Dalmasso AP
    Rev Clin Esp; 1996 Mar; 196 Spec No():44-51. PubMed ID: 9206808
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunoaffinity methods for purification of complement components and regulators.
    Morgan BP
    Methods Mol Biol; 2000; 150():53-60. PubMed ID: 10857101
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibody spectrum and anticomplementary activity of a plasmin-treated human immunoglobulin preparation.
    Masuda K; Makula MF; Okuyama K; Ishiyama H; Yasuda J
    Vox Sang; 1982 Jan; 42(1):8-15. PubMed ID: 6460384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement inhibition rescued mice allowing observation of transgene expression following intraportal delivery of baculovirus in mice.
    Hoare J; Waddington S; Thomas HC; Coutelle C; McGarvey MJ
    J Gene Med; 2005 Mar; 7(3):325-33. PubMed ID: 15521052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases.
    Rooijakkers SH; Ruyken M; Roos A; Daha MR; Presanis JS; Sim RB; van Wamel WJ; van Kessel KP; van Strijp JA
    Nat Immunol; 2005 Sep; 6(9):920-7. PubMed ID: 16086019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction to antibodies and complement.
    Moulds JM
    Transfus Apher Sci; 2009 Jun; 40(3):185-8. PubMed ID: 19410515
    [No Abstract]   [Full Text] [Related]  

  • 11. Complement-dependent platelet degradation and anaphylactoid shock in mice induced by lipopolysaccharide carrying the mannose homopolymer.
    Endo Y; Yokochi T; Matsushita M; Fujita T; Takada H
    J Endotoxin Res; 2001; 7(6):451-5. PubMed ID: 11753216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular mechanisms of formation of complexes between complement and immunoglobulins].
    Konstantinova NA; Lavrent'ev VV; Koval'chuk LV; Petrov RV
    Biull Eksp Biol Med; 1980 Sep; 90(9):328-30. PubMed ID: 7191736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of decay-accelerating factor into the baculovirus envelope generates complement-resistant gene transfer vectors.
    Hüser A; Rudolph M; Hofmann C
    Nat Biotechnol; 2001 May; 19(5):451-5. PubMed ID: 11329015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of regional analgesia and surgical trauma on selected factors of the human immune system].
    Gajdosz R
    Folia Med Cracov; 1994; 35(1-4):69-86. PubMed ID: 8586330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complement system: biological functions].
    Santaella ML
    Bol Asoc Med P R; 1981 May; 73(5):209-15. PubMed ID: 7034739
    [No Abstract]   [Full Text] [Related]  

  • 16. [The functional unity of the complement system and mononuclear phagocytes (author's transl)].
    Bitter-Suermann D
    Verh Dtsch Ges Pathol; 1980; 64():63-76. PubMed ID: 7013340
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mechanism of immunosuppressive action of glycoproteins].
    Ionov ID; Kovalev IE
    Patol Fiziol Eksp Ter; 1975; (2):57-60. PubMed ID: 1187212
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of the complement system in virus infections.
    Spear GT; Hart M; Olinger GG; Hashemi FB; Saifuddin M
    Curr Top Microbiol Immunol; 2001; 260():229-45. PubMed ID: 11443876
    [No Abstract]   [Full Text] [Related]  

  • 19. Complement in host defense.
    Schultz DR
    Scand J Infect Dis Suppl; 1980; Suppl 24():22-9. PubMed ID: 7010559
    [No Abstract]   [Full Text] [Related]  

  • 20. [Complement in 1994: clinical importance and perspectives].
    Binet I; Schifferli J
    Praxis (Bern 1994); 1995 Apr; 84(14):399-401. PubMed ID: 7724950
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.